Charline Ogier

530 total citations
7 papers, 216 citations indexed

About

Charline Ogier is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Charline Ogier has authored 7 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Charline Ogier's work include Pancreatic and Hepatic Oncology Research (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Cells and Metastasis (2 papers). Charline Ogier is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Cells and Metastasis (2 papers). Charline Ogier collaborates with scholars based in France and United States. Charline Ogier's co-authors include Tangui Maurice, Charleine Zussy, Laurent Givalois, Anthony Brureau, G. Ixart, Thierry Chardès, Véronique Garambois, André Pèlegrin, Christel Larbouret and Marta Jarlier and has published in prestigious journals such as International Journal of Cancer, Cancer Letters and Neurobiology of Aging.

In The Last Decade

Charline Ogier

7 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charline Ogier France 5 87 67 48 36 34 7 216
Ryutaro Kajihara Japan 13 102 1.2× 129 1.9× 51 1.1× 14 0.4× 21 0.6× 21 323
Sarada Preeta Kalainayakan United States 6 18 0.2× 163 2.4× 61 1.3× 26 0.7× 9 0.3× 6 352
Melinda Czéh Germany 5 96 1.1× 84 1.3× 43 0.9× 15 0.4× 46 1.4× 6 401
Adam Neal United States 10 66 0.8× 128 1.9× 36 0.8× 8 0.2× 10 0.3× 12 311
Anne-Claire Dupont France 6 26 0.3× 84 1.3× 76 1.6× 17 0.5× 31 0.9× 10 302
Hongqi Xiao China 11 36 0.4× 199 3.0× 11 0.2× 16 0.4× 25 0.7× 21 373
Phillip S. Gross United States 7 34 0.4× 51 0.8× 55 1.1× 14 0.4× 17 0.5× 15 190
K. S. Zänker Germany 7 130 1.5× 130 1.9× 8 0.2× 23 0.6× 4 0.1× 13 385
Rita Holdhus Norway 8 24 0.3× 153 2.3× 64 1.3× 5 0.1× 15 0.4× 9 308
Ryan J. Duchatel Australia 9 29 0.3× 83 1.2× 3 0.1× 17 0.5× 32 0.9× 12 247

Countries citing papers authored by Charline Ogier

Since Specialization
Citations

This map shows the geographic impact of Charline Ogier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charline Ogier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charline Ogier more than expected).

Fields of papers citing papers by Charline Ogier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charline Ogier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charline Ogier. The network helps show where Charline Ogier may publish in the future.

Co-authorship network of co-authors of Charline Ogier

This figure shows the co-authorship network connecting the top 25 collaborators of Charline Ogier. A scholar is included among the top collaborators of Charline Ogier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charline Ogier. Charline Ogier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Restifo, Diana, Dusica Cvetković, Charline Ogier, et al.. (2023). Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies. Molecular Cancer Therapeutics. 22(10). 1182–1190. 2 indexed citations
2.
Francescone, Ralph, Janusz Franco‐Barraza, Débora B. Vendramini‐Costa, et al.. (2022). NetrinG1+ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress. Cancer Research Communications. 2(9). 1017–1036. 27 indexed citations
3.
Bourgier, C., Nadège Gaborit, Véronique Garambois, et al.. (2019). An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. International Journal of Cancer. 145(7). 1838–1851. 42 indexed citations
4.
Ogier, Charline, Pierre‐Emmanuel Colombo, Corinne Bousquet, et al.. (2018). Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Letters. 432. 227–236. 43 indexed citations
5.
Clorennec, Christophe Le, Hervé Bazin, Olivier Dubreuil, et al.. (2017). Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3. Molecular Cancer Therapeutics. 16(7). 1312–1323. 13 indexed citations
6.
Brureau, Anthony, Charleine Zussy, Charline Ogier, et al.. (2012). Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model. Neurobiology of Aging. 34(5). 1426–1439. 88 indexed citations
7.
Ogier, Charline, et al.. (1984). [Decreased percentage of circulating T-lymphocytes in patients with thalassemic trait].. PubMed. 31(1). 58–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026